Comprehensive immunization delivery in conjunction with influenza vaccination.
All patients and employees presenting for influenza A and B vaccination were studied for the need for other immunizations or tests, based on criteria of the Immunization Practices Advisory Committee. More than 72% of patients and employees needed at least one other vaccine or test. During a 4 1/2-month period, 1,353 doses of influenza virus vaccine, bivalent, types A and B, were prescribed. Health care providers ordered doses of diphtheria and tetanus toxoids (adult) for 36.8% of these recipients, pneumococcal vaccine, polyvalent 23, for 42.1%, and a tuberculin skin test for 36.3%. Determinations of hepatitis B titers or hepatitis B vaccine doses were ordered for 140 individuals. Patients older than 60 years needed additional immunizations with greater frequency. Rates of delayed adverse reactions (35.9%) and subsequent self-medication (11.7%) were recorded. The systemic adverse reaction rate was 17.3%. Annual influenza vaccination programs are valuable public health opportunities to determine immunizations needed by patients who might not otherwise receive a comprehensive, individualized review of the status of their immunization protection.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000008:administration & dosage; D004168:Diphtheria Toxoid / Q000008:administration & dosage; D004219:District of Columbia; D005260:Female; D006801:Humans; D007114:Immunization; D007117:Immunization, Secondary; D007252:Influenza Vaccines / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D008889:Military Personnel; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D013296:Streptococcus pneumoniae / Q000276:immunology; D013745:Tetanus Toxoid / Q000008:administration & dosage; D014374:Tuberculin Test; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage
D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D007252:Influenza Vaccines; D011054:Poliovirus Vaccine, Inactivated; D013745:Tetanus Toxoid; D014761:Viral Hepatitis Vaccines